Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2010

View Archived Issues

EVX-001688 improves spatial memory in young and aged rats

Phase Ia trial demonstrates safety of SGN-70 in healthy subjects

GRN-529 has antidepressant, anxiolytic and analgesic effects in vivo

Boehringer Ingelheim describes novel mTOR inhibitors

FDA clears Advanced Cell Technology's phase I/II RPE trial

NeuroSearch claims new activators of voltage-gated K(V)7.2/3 potassium channel

SkyePharma advances two phase III trials of asthma candidate Flutiform in Japan

BMS-582949 shows promise to treat rheumatoid arthritis

LCZ-696 is well tolerated by patients with chronic stable heart failure in phase II trial

First-in-human data disclosed on dual PI3K/mTOR inhibitors PF-05212384 and PF-04691502

FG-4592 is safe and increases hemoglobin levels in CKD-related anemia

Roche to develop diagnostic tests to detect EGFR mutations in lung cancer

Abbott patents new serotonin 5-HT2C receptor agonists

Pivotal phase III trial of IPX-066 in early PD meets primary endpoint

Baxter and Archemix enter into agreements covering hemophilia-related assets

GW and Otsuka Pharma begin phase III cancer pain program for Sativex

Achaogen claims novel carbacephem beta-lactam antibiotics

GlaxoSmithKline discloses new orexin receptor antagonists

CEL-SCI completes global investigator meeting on phase III Multikine trial

Gilead submits NDA to FDA for single-tablet Truvada/TMC-278 combination

Vertex Pharma submits NDA to FDA for telaprevir in hepatitis C

FDA approves testosterone replacement therapy Axiron

Grifols launches Flebogamma 10% DIF in U.S.

SIRS-Lab and Pfizer collaborate on diagnostic tests to benefit patients with sepsis

Gablofen injection approved in U.S. for severe spasticity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...